Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,006 public trials 1,218 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions: Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Henry Ford Hospital Detroit, Michigan, United States

Upmc Cancercenter Pittsburgh, Pennsylvania, United States

Md Anderson Cancer Center Houston, Texas, United States

View all 21 locations

View Trial Details

Completed

Lerapolturev in Recurrent Malignant Glioma

NCT02986178

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations: UCSF Neurological Surgery San Francisco, California, United States

Baptist MD Anderson Cancer Center Jacksonville, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy

NCT02990611

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution - 0001 Essen, Germany

View Trial Details

Completed

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

NCT04581382

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

NCT02836548

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands

View Trial Details

Completed

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

NCT02611024

Conditions: Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
Locations: Sarcoma Oncology Center Santa Monica, California, United States

Massachusetts General Hospital - Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View all 23 locations

View Trial Details

Completed

How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.

NCT06654999

Conditions: Basal Cell Cancer, Melanoma, Melanoma of Skin, +16 more
Locations: Norwich and Norfolk Hospitals Trust Norwich, United Kingdom

University Hospitals Dorset Poole, United Kingdom

Surrey and Sussex Hospital Trust Redhill, United Kingdom

View Trial Details

Completed

HUMC 1612: Optune NovoTTF-200A System

NCT03128047

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations: Arnold Palmer Hospital for Children Orlando, Florida, United States

Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

NCT03439332

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Universitat Politècnica de València Valencia, Spain

View Trial Details

Completed

BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels

NCT05375318

Conditions: Astrocytoma, Astrocytoma, Grade IV, Glioblastoma, +14 more
Locations: Biomedical Data Science Lab. Universitat Politècnica de València Valencia, Spain

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions